This article was originally published in The Rose Sheet
The market for cosmeceuticals sold across mass, department, specialty and other retailers in the U.S. was estimated to be around $500 mil.-$600 mil. in 2005, according to Karen Young, president of marketing firm The Young Group. Exec presented during the Strategic Research Institute-sponsored Cosmeceuticals meeting in New York City June 8-9. In her presentation "Getting Your Brand Into the Channels That Count," Young noted the Internet remains an excellent means to attract new customers to a brand, and 80% of consumers regularly or occasionally purchase products online...
You may also be interested in...
Syndax CEO also says US FDA’s virtual meetings would benefit from having advisory committee members on camera, which may be a technology challenge.
Heading into an advisory committee review, agency suggests belantamab’s risks of keratopathy and other ocular issues have not been fully characterized and questions whether the proposed mitigation measures, including dosing modifications, are adequate.
The Phase III FIDELIO trial of finerenone has been a success but analysts want to see some actual data before declaring it an unqualified one.